Related Experiment Video
Updated: Jun 15, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Risk Assessment of Cognitive Impairment at 2 Years of Age in Infants Born Extremely Preterm Using the
Ariel A Salas1, Waldemar A Carlo1, Carla M Bann2
1Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL.
Insights
Monitoring infant growth using INTERGROWTH-21st standards can identify extremely preterm infants at risk for cognitive impairment. Length and head circumference z-scores are key indicators for early intervention.
Area of Science:
- Neonatalogy
- Developmental Pediatrics
- Pediatric Neurology
Background:
- Extremely preterm infants face heightened risks for neurodevelopmental challenges.
- The INTERGROWTH-21st standards provide a framework for assessing fetal and newborn growth.
- Early identification of cognitive impairment risk is crucial for timely intervention.
Purpose of the Study:
- To evaluate the utility of INTERGROWTH-21st standards in predicting cognitive impairment in extremely preterm infants.
- To identify specific anthropometric markers and growth patterns associated with cognitive deficits at two years of age.
- To refine definitions of growth failure and faltering for improved risk assessment.
Main Methods:
- Analysis of anthropometric data (birth and 36 weeks postmenstrual age) from 5393 extremely preterm infants (24-26 weeks gestation).
- Utilized classification and regression trees to determine INTERGROWTH-21st z-score thresholds for cognitive impairment risk (Bayley cognitive score <85).
- Redefined growth failure (z-scores at 36 weeks PMA) and growth faltering (z-score declines from birth to 36 weeks PMA).
Main Results:
- Growth failure (weight z-score ≤ -1.8 at 36 weeks PMA) and growth faltering (weight z-score decline ≥ 1.1) were linked to higher cognitive impairment likelihood.
- Length z-score < -1 at 36 weeks PMA demonstrated the highest sensitivity (80%) for detecting cognitive impairment.
- Head circumference z-score decline ≥ 2.43 showed the highest specificity (86%) in risk detection.
Conclusions:
- Length and head circumference z-scores are sensitive and specific indicators for predicting cognitive impairment in extremely preterm infants.
- Monitoring these growth parameters can facilitate earlier, individualized interventions.
- Optimized growth monitoring may help mitigate the risk of cognitive impairment in this vulnerable population.
Objective:
To assess the risk of cognitive impairment among infants born extremely preterm using the INTERGROWTH-21st standards.
Study Design:
We analyzed anthropometric data at birth and 36 weeks postmenstrual age (PMA) from infants born extremely preterm (24-26 weeks of gestation) admitted to US neonatal units between 2008 and 2018. To determine INTERGROWTH-21st z-score values that indicate an increased risk of cognitive impairment at 2 years of age (Bayley cognitive score <85), we employed classification and regression trees and redefined growth failure (weight, length, and head circumference z-scores at 36 weeks PMA) and growth faltering (weight, length, and head circumference z-score declines from birth to 36 weeks PMA).
Results:
Among 5393 infants with a mean gestational age of 25 weeks, growth failure defined as a weight z-score of -1.8 or below at 36 weeks PMA and growth faltering defined as a weight z-score decline of 1.1 or greater from birth to 36 weeks PMA indicated a higher likelihood of cognitive impairment. A length z-score less than -1 at 36 weeks PMA had the highest sensitivity to detect cognitive impairment at 2 years (80%). A head circumference z-score decline of 2.43 or greater from birth to 36 weeks PMA had the highest specificity (86%). Standard definitions had fair to low sensitivity and specificity for risk detection of cognitive impairment.
Conclusions:
Length and head circumference z-scores had the highest sensitivity and specificity for risk detection of cognitive impairment. Monitoring these growth parameters could guide earlier individualized interventions with potential to reduce cognitive impairment.
Clinical Trial Registration:
ClinicalTrials.gov ID Generic Database: NCT00063063.
More Related Videos
Related Concept Videos
Intellectual Disability
Piaget's Stage 1 of Cognitive Development
The Nativist Approach

